Bernstein: Alexion Pharma An Outperform, Worth $267/Share
June 23, 2015 at 09:50 AM EDT
In a report published Tuesday, Bernstein analyst Geoffrey C. Porges reiterated an Outperform rating on Alexion Pharmaceuticals, Inc. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.